Gui Y

No ORCID on file · 6 papers in corpus · active 1999-2026

Study types

  • other 3
  • article 2

Condition tags

  • endometriosis 4
  • dysmenorrhea 1
  • chronic_pelvic_pain 1
  • infertility 1
  • adenomyosis 1
other 2026
Human genomics ·doi:10.1186/s40246-026-00934-x

BACKGROUND: Endometriosis (EMs) is a prevalent gynecologic disorder that often causes severe chronic pelvic pain and infertility. Although genome-wide association studies have identified common variants of EMs, the contribution of rare vari…

2025
Oncology letters ·doi:10.3892/ol.2025.15320

Retroperitoneal squamous cell carcinoma (SCC) is an extremely rare tumor originating from the retroperitoneum, with an unclear etiology and origin. Imaging studies are the preferred diagnostic modality for retroperitoneal tumors. The presen…

other 2021
World neurosurgery ·doi:10.1016/j.wneu.2020.10.137

The paper aims to understand the expression of nerve growth factor receptor (TrkA) in the ectopic and entopic endometrium of patients with adenomyosis and dysmenorrhea and, at the same time, explore and analyze the combination of hysterosco…

other 2018
BioMed research international ·doi:10.1155/2018/5208964

Molecular imaging of estrogen receptor-positive (ER+) pathway-activated system serves the basis of ER+ disease management such as cancers and endometriosis. ER+ patients have better response to endocrine therapy and survive twice as long as…

article 2016
Evidence-based complementary and alternative medicine : eCAM ·doi:10.1155/2016/5649169

We evaluated the effectiveness of Kuntai Capsule (KTC) for treating endometriosis using rat model and investigated its preliminary mechanism of action involved. SD rats were implanted with endometrial tissues and treated with KTC for three …

article 1999
Molecular human reproduction ·doi:10.1093/molehr/5.9.866

HOXA-10 is a member of a family of genes that serve as transcription factors during development and have been shown to be important for uterine function. Using immunohistochemistry and RNAse protection assays (RPA), HOXA-10 was shown to be …